Form 8-K - Current report:
SEC Accession No. 0001654954-25-003552
Filing Date
2025-03-28
Accepted
2025-03-28 17:01:04
Documents
19
Period of Report
2025-03-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K drma_8k.htm   iXBRL 8-K 47424
2 FORM OF NEW WARRANT. drma_ex41.htm EX-4.1 101562
3 FORM OF HCW WARRANT drma_ex42.htm EX-4.2 101738
4 FORM OF INDUCEMENT LETTER drma_ex101.htm EX-10.1 54801
5 PRESS RELEASE drma_ex991.htm EX-99.1 11371
  Complete submission text file 0001654954-25-003552.txt   539938

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA drma-20250327.xsd EX-101.SCH 6311
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE drma-20250327_lab.xml EX-101.LAB 16902
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE drma-20250327_cal.xml EX-101.CAL 898
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE drma-20250327_pre.xml EX-101.PRE 12342
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE drma-20250327_def.xml EX-101.DEF 4203
21 EXTRACTED XBRL INSTANCE DOCUMENT drma_8k_htm.xml XML 5823
Mailing Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130
Business Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130 (858)-223-0882
Dermata Therapeutics, Inc. (Filer) CIK: 0001853816 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40739 | Film No.: 25787419
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)